本文選題：埃博拉病毒　切入點：血液療法　出處：《中國輸血雜志》2015年03期

【摘要】：正目前正在西非部分地區(qū)肆虐的埃博拉病毒性疾病(Ebora virus disease,EVD)疫情是近代最嚴(yán)重的緊急突發(fā)公共衛(wèi)生事件,是歷史記載中從未有過的疫情:病原體生物安全等級如此之高(4級,最高級),感染傳播速度如此之快,傳播范圍如此之廣,感染人數(shù)如此之多,病死率如此之高(3個疫區(qū)均約達(dá)70.8%),持續(xù)時間如此之久,防控措施如此之缺。在3個受影響最嚴(yán)重的國家,幾內(nèi)亞、利比里亞和塞拉利昂,
[Abstract]:The Ebola virus disease, Ebora virus disease, is the most serious public health emergency in modern times and has never been recorded in history: the biological safety level of pathogens is so high that it is grade 4. At the top of the spectrum, the rate of transmission is so fast, the spread is so wide, the number of people infected is so large, the mortality rate is so high (all three epidemic areas are about 70.8%), which lasts such a long time. In three of the most affected countries, Guinea, Liberia and Sierra Leone,
【作者單位】： 福建省血液中心福建醫(yī)科大學(xué)輸血醫(yī)學(xué)教研室;
【分類號】：R512.8

【相似文獻(xiàn)】

相關(guān)期刊論文 前2條

1 ;西非埃博拉病毒病-最新簡報[J];疾病監(jiān)測;2014年06期

2 ;[J];;年期

，

本文編號：1691132